Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCBP.L Regulatory News (CBP)

  • There is currently no data for CBP

Trading Update

16 Jan 2018 07:00

RNS Number : 9351B
Curtis Banks Group PLC
16 January 2018
 

16 January 2018

 

Curtis Banks Group plc

("Curtis Banks", the "Company")

Trading Update

Curtis Banks, one of the UK's leading SIPP providers, today issues the following trading update for the year ended 31 December 2017.

Consolidation and integration of the Company since the acquisition of the Suffolk Life Group of companies in May 2016 has advanced during the year and the results for 2017 will be the first to include full year results for Suffolk Life.

The Company is pleased to announce that trading during 2017 has been in line with management expectations. The business is well positioned for further growth in 2018.

Highlights are:

· New SIPPs during the year amounted to 8,798, and overall SIPP numbers increased to 76,474. Attrition rates on own SIPPs have remained in line with previous years at 5.7%. As at the year end the Company had assets under administration of £24.7 billion (2016 £20.4 billion).

· Group cash balances at 31 December 2017 amounted to £25.4 million gross (2016: £21.5 million) and £7.7 million net of debt (2016: £0.5 million)

· A Group Sales Director, Dave Stratton, has been appointed. Dave was previously Head of IFA Distribution at AXA Wealth and joins with substantial industry experience. His role is to align and develop the sales processes across the group companies and further increase organic sales.

· The Company's credit rating from AKG, which assesses the strength of financial services companies, has increased to Strong, which is an endorsement of the size and strength of the business for our clients and advisers.

Rupert Curtis, CEO, commented:

"2017 has been a year of building on our already strong foundations and aligning the Curtis Banks and Suffolk Life operations, as well as achieving high organic growth. We have made significant progress and are now well-placed to drive the business forward in 2018."

The results for the year ended 31 December 2017 will be announced on Thursday 15 March 2018. 

 

Investor and Analyst Presentation

 

There will be a presentation on Thursday 15 March 2018 at 9.30am for institutional investors and analysts at Peel Hunt, Moor House, 120 London Wall, London EC2Y 5ET. Those wishing to attend should contact jane.glover@camarco.co.uk.

 

 

 

For more information: 

 

Curtis Banks Group plc

www.curtisbanks.co.uk

Rupert Curtis - Chief Executive Officer

+44 (0) 117 9107910

Will Self - Deputy Chief Executive Officer

 

Paul Tarran - Chief Financial

 

 

 

Peel Hunt LLP (Nominated Adviser & Broker)

+44 (0) 20 7418 8900

Guy Wiehahn

 

Rishi Shah

 

 

 

Camarco

+44 (0) 20 3757 4984

Ed Gascoigne-Pees

 

Hazel Stevenson

 

 

 

Notes to Editors: 

 

Curtis Banks administers over 76,000 Self-Invested Pension Schemes, principally SIPPs and SSASs. The Group commenced trading in 2009 and has successfully developed, through a combination of organic growth and acquisitions, into one of the largest UK providers of these products. The Group employs approximately 570 staff in its head office in Bristol and regional offices in Ipswich, Dundee and Market Harborough.

 

For more information - www.curtisbanks.co.uk

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFLDLEIELIT
Date   Source Headline
1st Nov 20214:35 pmRNSPrice Monitoring Extension
21st Oct 20214:41 pmRNSHolding(s) in Company
21st Oct 20212:48 pmRNSHolding(s) in Company
20th Oct 20213:08 pmRNSHolding(s) in Company
20th Oct 20217:00 amRNSDirector/PDMR Dealing
11th Oct 20219:38 amRNSDirector/PDMR Dealing
22nd Sep 20211:00 pmRNSDividend Timetable
9th Sep 20217:00 amRNSInterim Results
1st Sep 20214:35 pmRNSTR-1: Notification of major holdings
19th Jul 20217:00 amRNSTrading Update
25th Jun 20213:00 pmRNSHolding(s) in Company
9th Jun 20217:00 amRNSTR1: Notification of Major Holdings
8th Jun 20212:55 pmRNSDirector/PDMR Shareholding
3rd Jun 20212:03 pmRNSDirector/PDMR Shareholding
27th May 20214:40 pmRNSResult of AGM
12th May 20215:11 pmRNSCorrection to Notice of Annual General Meeting
30th Apr 20217:00 amRNSAnnual Report & Accounts and Notice of AGM
28th Apr 20217:00 amRNSDirector/PDMR Shareholding
19th Apr 20214:24 pmRNSDirector/PDMR Shareholding
12th Apr 20215:37 pmRNSDirector/PDMR Shareholding
8th Apr 20215:59 pmRNSHolding(s) in Company
7th Apr 20217:00 amRNSFinal Results
17th Mar 20217:00 amRNSUpdate on Timing of Full Year Results Announcement
5th Feb 202110:12 amRNSHolding(s) in Company
19th Jan 20217:00 amRNSAppointment of Non-Executive Director
12th Jan 20217:00 amRNSTrading Update
18th Dec 20207:00 amRNSDirector/PDMR Shareholding
30th Nov 20207:00 amRNSTrading and Operations Update
26th Nov 20204:49 pmRNSHolding(s) in Company
13th Nov 20204:33 pmRNSHolding(s) in Company
12th Nov 20207:00 amRNSDirector/PDMR Shareholding
28th Oct 202010:00 amRNSDirector/PDMR Shareholding
6th Oct 20207:00 amRNSCompletion of acquisition of Talbot and Muir
5th Oct 20204:40 pmRNSSecond Price Monitoring Extn
5th Oct 20204:35 pmRNSPrice Monitoring Extension
14th Sep 20207:00 amRNSLong-Term Incentive Plan
7th Sep 20207:01 amRNSInvestor Presentation
7th Sep 20207:00 amRNSDividend timetable
3rd Sep 20207:00 amRNSInterim Results
25th Aug 20204:41 pmRNSSecond Price Monitoring Extn
25th Aug 20204:36 pmRNSPrice Monitoring Extension
4th Aug 20207:00 amRNSNotice of Results
30th Jul 202012:26 pmRNSHolding(s) in Company
28th Jul 20209:20 amRNSHolding(s) in Company
27th Jul 20206:14 pmRNSHolding(s) in Company
23rd Jul 20202:20 pmRNSResult of placing
23rd Jul 20207:27 amRNSProposed Placing to raise £25m
23rd Jul 20207:25 amRNSAcquisition of Talbot and Muir and Dunstan Thomas
16th Jun 20204:41 pmRNSSecond Price Monitoring Extn
16th Jun 20204:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.